1. A new standard of care for mantle cell lymphoma?. Issue 1 (January 2016) Authors: Rule, Simon Journal: Lancet oncology Issue: Volume 17:Issue 1(2016:Feb.) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Issue 2 (February 2016) Authors: Chanan-Khan, Asher; Cramer, Paula; Demirkan, Fatih; Fraser, Graeme; Silva, Rodrigo Santucci; Grosicki, Sebastian; Pristupa, Aleksander; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L; Dilhuydy, Marie-Sarah; Pylypenko, Halyna; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Villa, Diego; Samoil... Journal: Lancet oncology Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study. Issue 10020 (20th February 2016) Authors: Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Silva, Rodrigo Santucci; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D; Enny, Christopher; Traina... Journal: Lancet Issue: Volume 387:Issue 10020(2016) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial. Issue 3 (March 2016) Authors: Trněný, Marek; Lamy, Thierry; Walewski, Jan; Belada, David; Mayer, Jiri; Radford, John; Jurczak, Wojciech; Morschhauser, Franck; Alexeeva, Julia; Rule, Simon; Afanasyev, Boris; Kaplanov, Kamil; Thyss, Antoine; Kuzmin, Alexej; Voloshin, Sergey; Kuliczkowski, Kazimierz; Giza, Agnieszka; Milpied, No... Journal: Lancet oncology Issue: Volume 17:Issue 3(2016:Mar.) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib. (12th May 2016) Authors: Tucker, David L.; Mihailescu, Loredana; Riordan, Richard; Rule, Simon Journal: British journal of haematology Issue: Volume 178:Number 1(2017) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The use of Bruton's tyrosine kinase inhibition as a bridging strategy to successful allogeneic stem cell transplant in relapsed mantle cell lymphoma. Issue 2 (1st February 2016) Authors: Furtado, Michelle; Clarke, Kathleen; Medd, Patrick; Hunter, Hannah; Rule, Simon Journal: Leukemia & lymphoma Issue: Volume 57:Issue 2(2016:Feb.) Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗